The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $281.77

Today's change-2.65 -0.93%
Updated August 18 4:00 PM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $281.77

Today's change-2.65 -0.93%
Updated August 18 4:00 PM EDT. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$2.65

Biogen Inc closed lower Friday, dropping (U.S.)$2.65 or 0.93% to (U.S.)$281.77. Shares have lost 0.67% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 20.99% during the last year.

Key company metrics

  • Open(U.S.) $283.31
  • Previous close(U.S.) $284.42
  • High(U.S.) $285.67
  • Low(U.S.) $281.65
  • Bid / Ask(U.S.) $254.82 / (U.S.) $282.25
  • YTD % change-0.64%
  • Volume814,072
  • Average volume (10-day)1,030,268
  • Average volume (1-month)1,241,338
  • Average volume (3-month)1,459,887
  • 52-week range(U.S.) $244.28 to (U.S.) $329.83
  • Beta0.80
  • Trailing P/E18.50×
  • P/E 1 year forward13.14×
  • Forward PEG1.88×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $15.23
Updated August 18 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.54%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue3,0782,8112,8722,956
Total other revenue--------
Total revenue3,0782,8112,8722,956
Gross profit2,7122,4262,4942,539
Total cost of revenue366385379417
Total operating expense1,8781,7861,9861,531
Selling / general / administrative430499496463
Research & development796423534529
Depreciation / amortization118449104100
Interest expense (income), net operating--------
Unusual expense (income)1411046318
Other operating expenses, total2721115
Operating income1,2011,0248861,425
Interest income (expense), net non-operating-64-63-65-66
Gain (loss) on sale of assets--------
Other--------
Income before tax1,1329878381,367
Income after tax8637486481,030
Income tax, total270239190337
Net income8637486491,033
Total adjustments to net income--------
Net income before extra. items8637486491,033
Minority interest0013
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8637486491,033
Inc. avail. to common incl. extra. items8637486491,033
Diluted net income8637486491,033
Dilution adjustment--------
Diluted weighted average shares212216217219
Diluted EPS excluding extraordinary itemsvalue per share4.073.462.994.71
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.713.504.644.77